Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DRUG · NASDAQ · Pharmaceutical Preparations · Foreign private issuer
$20.40−0.30 (−1.45%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Bright Minds Biosciences (DRUG) · oqro.io/stocks/DRUG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Vivo Opportunity Fund Holdings, L.P. cut its DRUG stake below 5% (3.8%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC no longer reported DRUG for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed a reduced position in DRUG for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deerfield Management Company, L.P. disclosed a new position in DRUG for Q1 2026SourceInsider trade · Traded Apr 28, 2026 · Filed Apr 30, 2026
Insider sold ~$9.79M of DRUG shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC disclosed an increased position in DRUG for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in DRUG for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC disclosed an increased position in DRUG for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a new position in DRUG for Q4 2024SourceInsider trade · Traded Nov 4, 2024 · Filed Nov 6, 2024
10% owner purchased ~$4M of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$1.08M of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$374K of DRUG shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 17, 2024
10% owner purchased ~$923K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$214K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$225K of DRUG shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 17, 2024
10% owner purchased ~$172K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$65K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$57K of DRUG shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 17, 2024
10% owner purchased ~$78K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$25K of DRUG shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner purchased ~$23K of DRUG shares in the open marketSource